|Bid||1.51 x 2200|
|Ask||3.36 x 1400|
|Day's Range||2.5300 - 2.5900|
|52 Week Range||2.5300 - 6.5400|
|Beta (3Y Monthly)||2.10|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 5, 2019 - Mar 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
DUBLIN, Ireland, Nov. 29, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), today announced that Ronan O’Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity.
The big shareholder groups in Trinity Biotech plc (NASDAQ:TRIB) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller Read More...
DUBLIN, Ireland, Oct. 23, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory.
Conference Call Scheduled for October 23, 2018at 11:00 am EASTERN DUBLIN, Oct. 16, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of.
If you’re interested in Trinity Biotech plc (NASDAQ:TRIB), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock couldRead More...
Trinity Biotech (NASDAQ: TRIB ) announces its next round of earnings this Thursday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Trinity Biotech ...
Assessing Trinity Biotech plc’s (NASDAQ:TRIB) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...
The World Health Organization published this month a list of 113 “essential” in vitro diagnostics to guide member states in establishing standards for universal health coverage, inform donation selection ...
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Trinity Biotech Plc Sponsored ADR Class A (NASDAQ: TRIB ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018, at ...